Latest Research in CAR-T cell therapy research

Top Research Topics in CAR-T cell therapy research

• Prostate Cancer Treatment and Research — 3 papers
• CAR-T cell therapy research — 2 papers
• Magnolia and Illicium research — 1 papers
• Xenotransplantation and immune response — 1 papers
• Ferroptosis and cancer prognosis — 1 papers
• Cancer-related Molecular Pathways — 1 papers
• Influenza Virus Research Studies — 1 papers
• Chemical synthesis and alkaloids — 1 papers
• Cytokine Signaling Pathways and Interactions — 1 papers
• Blood groups and transfusion — 1 papers

Highest-Cited Papers

1. Adhiron binders as molecular tools for inhibiting activation dependent, IL-7 mediated long-term survival of CD4+ T-cells
2. A modular synthetic promoter toolkit for programmable gene control in activated and chronically stimulated T cells
3. Targeting the Androgen Receptor and Associated Cofactors in Prostate Cancer: Novel Approaches and Future Perspectives
4. The Transmembrane Envelope Protein of Porcine Endogenous Retroviruses Modulates Cytokine Release and Gene Expression in Human Immune Cells
5. Developing a Fluorescence-Based High-Throughput Screening Method for Natural Product Fractions to Identify Inhibitors of AR-V7 for Castration-Resistant Prostate Cancer
6. Graph neural network-based risk stratification of prostate cancer using gene expression and SHAP interpretability
7. Drugging the “undruggable” p53: a structure-guided strategy against the Y220C mutation
8. Zbtb46T11A Mutation Is Associated with Enhanced Influenza Vaccine Immunogenicity and Altered cDC1 Proportions in Mice
9. Clonotype-resolved T-cell response monitoring via repertoire-wide multidimensional TCR decoding
10. Overcoming Docetaxel Resistance in Prostate Cancer by Targeting Cell Cycle Progression with Narciclasine-Based Compounds
11. STAT3 phosphorylation as an endpoint in a functional cell-based neutralizing antibody assay with potential for broad application
12. Biochanin A inhibits the activity of androgen receptor mutants to suppress the development of prostate cancer
13. Pretransfusion testing interference profile of IMC ‐002: A novel anti‐ CD47 monoclonal antibody engineered for minimized red cell binding
14. Memory CD4+ T cells in chronic uveitis: pathogenicity, mechanisms, and therapeutic implications
15. CD97/ADGRE5 attenuates the induction of adaptive type 2 immune responses in allergic asthma